These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


489 related items for PubMed ID: 29688883

  • 1. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A.
    Clin Chem Lab Med; 2018 May 24; 56(6):990-1000. PubMed ID: 29688883
    [Abstract] [Full Text] [Related]

  • 2. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Apr 24; 50(6):285-292. PubMed ID: 27939727
    [Abstract] [Full Text] [Related]

  • 3. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A.
    Clin Chem Lab Med; 2017 May 01; 55(5):737-747. PubMed ID: 27930363
    [Abstract] [Full Text] [Related]

  • 4. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A.
    Mol Diagn Ther; 2017 Aug 01; 21(4):453-464. PubMed ID: 28405803
    [Abstract] [Full Text] [Related]

  • 5. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A.
    Clin Chem Lab Med; 2014 Aug 01; 52(8):1217-27. PubMed ID: 24615484
    [Abstract] [Full Text] [Related]

  • 6. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A.
    Tumour Biol; 2016 Sep 01; 37(9):11815-11824. PubMed ID: 27044381
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P, Ji DB, Han HB, Shi YF, Du CZ, Gu J.
    World J Gastroenterol; 2014 Sep 14; 20(34):12241-8. PubMed ID: 25232258
    [Abstract] [Full Text] [Related]

  • 8. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Nov 14; 50(16-17):918-924. PubMed ID: 28624481
    [Abstract] [Full Text] [Related]

  • 9. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
    Kalioraki MA, Artemaki PI, Sklirou AD, Kontos CK, Adamopoulos PG, Papadopoulos IN, Trougakos IP, Scorilas A.
    Mol Carcinog; 2020 Jan 14; 59(1):116-125. PubMed ID: 31709619
    [Abstract] [Full Text] [Related]

  • 10. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma.
    Adamopoulos PG, Kontos CK, Rapti SM, Papadopoulos IN, Scorilas A.
    Int J Oncol; 2015 Feb 14; 46(2):849-59. PubMed ID: 25420464
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.
    World J Gastroenterol; 2014 Aug 28; 20(32):11340-6. PubMed ID: 25170220
    [Abstract] [Full Text] [Related]

  • 12. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A.
    Sci Rep; 2017 Mar 06; 7():43393. PubMed ID: 28262692
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Wang X, Wang J, Ma H, Zhang J, Zhou X.
    Med Oncol; 2012 Jun 06; 29(2):919-27. PubMed ID: 21390519
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP, Huang CC, Yeh KT, Ke TW, Wei PL, Yang JR, Cheng YW.
    Surg Oncol; 2016 Dec 06; 25(4):429-434. PubMed ID: 27262492
    [Abstract] [Full Text] [Related]

  • 15. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
    Pantazis TL, Giotakis AI, Karamagkiolas S, Giotakis I, Konstantoulakis M, Liakea A, Misiakos EP.
    Am J Otolaryngol; 2020 Dec 06; 41(5):102563. PubMed ID: 32521298
    [Abstract] [Full Text] [Related]

  • 16. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF, Li YC, Wang Y, Sun LB.
    Cell Physiol Biochem; 2018 Dec 06; 50(1):196-213. PubMed ID: 30278464
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.
    Fang L, Li H, Wang L, Hu J, Jin T, Wang J, Yang BB.
    Oncotarget; 2014 May 30; 5(10):2974-87. PubMed ID: 24912422
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer.
    Christodoulou S, Sotiropoulou CD, Vassiliu P, Danias N, Arkadopoulos N, Sideris DC.
    Int J Mol Sci; 2023 Jun 10; 24(12):. PubMed ID: 37373137
    [Abstract] [Full Text] [Related]

  • 19. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y, Mu N.
    Ann Clin Biochem; 2017 Jan 10; 54(1):127-133. PubMed ID: 27166306
    [Abstract] [Full Text] [Related]

  • 20. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov 10; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.